Cloudflare (NET) reportedly facing issues on certain custom domains
Newsquawk Staff ·
Cloudflare (NET) reportedly facing issues on certain custom domains.
What it means
Cloudflare sits in the middle of a large share of internet traffic, so incidents at the company have historically produced two distinct reads: the equity reaction, which has tended to be brief and recovered as service restored, and the knock-on visibility of outages across customer sites, which in past episodes spread the headline beyond the stock itself. The operative distinction is scope: an issue confined to certain custom domains reads as a configuration or edge-case problem rather than a core network failure, and prior limited-scope incidents have resolved without lasting reputational or revenue damage. What has mattered in comparable episodes is duration and whether the company attributes cause quickly; prolonged ambiguity has historically been the trigger for customer-churn questions and for short-seller attention, given the stock's history as a high-multiple momentum name. Worth watching is the incident page cadence, any disclosure of affected-traffic share, and whether peers in the content-delivery and security space catch a sympathy bid, which has been the usual pattern when a leader stumbles. As a service incident rather than a financial disclosure, the informational content is low until the company quantifies it.
- European S&P Global Composite PMI Flash (Oct) 51.9 vs. Exp. 52.7 (Prev. 53.1)
- German S&P Global Manufacturing PMI Flash (Oct) 54.2 vs. Exp. 53.5 (Prev. 53.9)
- French S&P Global Composite PMI Flash (Oct) 48.4 vs. Exp. 50.5 (Prev. 51.1)
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)
Related headlines
- UK Retail Sales (Sep MM) -0.4% vs. Exp. -0.1% (Prev. 0.7%)2 hours ago
- Ukraine energy company DTEK says a Russian attack hit one of its power stations3 hours ago
- Saudi Civil Defense issues emergency danger warnings in Abha city and Khamis Mushait, but announces that danger has passed shortly after 6 hours ago
- Iran's IRGC threatens to target US bases if commercial ships continue transiting Strait of Hormuz, according to 6 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand8 hours ago
- Japanese CPI (Sep YY) 2.1% vs. Exp. 2.1% (Prev. 1.9%)9 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT10 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated10 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network10 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud11 hours ago
- US President Trump on Iran, says may do it a little bit further12 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash12 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)12 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)12 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone14 hours ago